Literature DB >> 1326493

Transcriptional activity of HIV-1 and HHV-6 in retinal lesions from AIDS patients.

H B Qavi1, M T Green, G K SeGall, D E Lewis, F B Hollinger.   

Abstract

This study determined the frequency of multiple viral (HIV-1, HHV-6, and CMV) infections in 26 retinas from 16 AIDS patients. Of the 12 retinas of 26 that tested positive for HIV-1 DNA sequences, seven also were positive for HHV-6 DNA sequences. Four of these seven retinas were culture positive for HIV-1 and two of the four contained CMV DNA sequences and antigens. Using RNA probes, HIV-1 and HHV-6 transcriptional activity was demonstrated in two of the four HIV-1 culture positive retinas. These retinas also contained CMV DNA sequences and antigens. The results demonstrate that more than 35% of AIDS patients suffer from at least two simultaneous viral infections and 15% suffer from three viral infections. The presence of transcriptional activity of HIV-1 and HHV-6 suggests an active infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326493

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Herpesvirus infection of eye and brain in HIV infected patients.

Authors:  R F Miller; M R Howard; P Frith; C J Perrons; I Pecorella; S B Lucas
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

3.  AIDS-related optic neuropathy: a histological, virological and ultrastructural study.

Authors:  A A Sadun; J S Pepose; M C Madigan; K A Laycock; W N Tenhula; W R Freeman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

Review 4.  Ocular manifestations of emerging viral diseases.

Authors:  Ashwin Venkatesh; Ravi Patel; Simran Goyal; Timothy Rajaratnam; Anant Sharma; Parwez Hossain
Journal:  Eye (Lond)       Date:  2021-01-29       Impact factor: 3.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.